Skip to content

Neurofeedback for Stroke Rehabilitation

The Use of Real-Time fMRI and a Mobile EEG System to Provide Neurofeedback to Stroke Patients to Promote Neural Plasticity for Motor Rehabilitation.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03775915
Enrollment
27
Registered
2018-12-14
Start date
2018-02-09
Completion date
2020-03-20
Last updated
2023-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Motor function, Brain activity

Brief summary

Real-time neurofeedback aims to alter brain activation patterns through online feedback of ongoing brain activity using magnetic resonance imagining (MRI). Stroke survivors will be randomised to receive 3 sessions of real or sham neurofeedback. This study aims to investigate whether: 1) stroke survivors can maintain alterations in brain activity after the feedback is removed, 2) neurofeedback training leads to improvements in movement of the hand and arm, 3) neurofeedback training leads to changes in brain structure and function, 4) variability in response across people can be understood.

Detailed description

Many stroke survivors experience impairment in upper limb function, reducing independence in activities of daily living. These impairments are associated with atypical brain activity patterns. Real-time neurofeedback aims to alter brain activation patterns through online feedback of ongoing brain activity using magnetic resonance imagining (MRI). Patterns of brain activity are displayed to a participant while a task is being performed. The participant is instructed to try to alter the patterns in a particular way, promoting specific brain activity patterns. Previous studies have found that people with and without stroke are capable of utilising the feedback to alter their brain activity. This study aims to investigate whether: 1. stroke survivors can maintain alterations in brain activity after the feedback is removed 2. neurofeedback training leads to improvements in movement of the hand and arm 3. neurofeedback training leads to changes in brain structure and function 4. variability in response across people can be understood. 30 stroke survivors (\> 6 months after stroke), with residual upper limb impairment, will be recruited between February 2018 and December 2020. Participants will be randomised to receive 3 sessions of real or sham neurofeedback over one week, taking place at the Wellcome Centre for Integrative Neuroimaging, University of Oxford. Changes in brain activity during affected hand movements will be assessed with and without feedback using functional MRI and after feedback sessions using electroencephalography (EEG). Brain connectivity and structure will also be assessed using MRI at baseline and at a follow-up one week later. Clinical measures of upper limb function and impairment will be performed at baseline and at follow up sessions one week and one month later (Action Research Arm Test, Fugl-Meyer upper limb assessment, Jebsen Taylor hand function test), and in each session following neurofeedback (Jebsen taylor test).

Interventions

OTHERNeurofeedback

A visual representation of the participants brain activity during movement of their affected hand in the MRI scanner.

A visual representation of brain activity pre-recorded from a previous participant

Sponsors

Wellcome Trust
CollaboratorOTHER
University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Participants are randomly allocated (1:1 ratio) to either the intervention group (Real Neurofeedback) or the control group (Sham Neurofeedback). Randomisation is done after participants undergo baseline measurements using a computer-generated minimisation method that takes into account baseline upper limb function (Action Research Arm test score) and time since stroke.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stroke \> 6 months previously * Unilateral upper limb impairment, but physically able to complete the tasks required

Exclusion criteria

* Contraindications to MRI, such as a pacemaker, metallic implants or aneurysm clips * Inability to provide informed consent * Inability to actively participate in the research procedures

Design outcomes

Primary

MeasureTime frameDescription
Hand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Throughout study completion, 5 assessment sessions spread over approximately 3 weeksPerformance on the Jebsen Taylor hand function test (time, in seconds to complete specified activities reflecting daily living)
Lateralisation of Brain ActivityThroughout the 3 intervention sessions, an average of 4 daysLateralisation of brain activity during movement of the affected hand, assessed using functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal. The activation in the region of interest is calculated for each hemisphere and the laterality index calculated as: (ipsilesional hemisphere - contralesional hemisphere) / (ipsilesional hemisphere + contralesional hemisphere). As such, positive values are indicative of greater activation in the ipsilesional hemisphere.

Secondary

MeasureTime frameDescription
Lateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)Baseline, 1 week follow upLateralisation of brain activity during a visuomotor squeeze task, assessed using functional magnetic resonance imaging (BOLD signal). The activation in the region of interest is calculated for each hemisphere and the laterality index calculated as: (ipsilesional hemisphere - contralesional hemisphere) / (ipsilesional hemisphere + contralesional hemisphere). As such, positive values are indicative of greater activation in the ipsilesional hemisphere.
Lateralisation of Brain Activity During Visuomotor Squeeze Task (EEG)Throughout study completion, an average of 3 weeksChange in lateralisation of brain activity during a visuomotor squeeze task, assessed using EEG
Upper Limb FunctionBaseline, 1 week follow upAction research arm test score (ARAT; upper limb function). Range 0-57, higher numbers indicate better upper limb function
Change in Upper Limb Function1 month follow upChange in action research arm test score (ARAT; upper limb function). Range 0-57, higher numbers indicate better upper limb function
Change in Resting State Functional Connectivity1 week follow upChange in resting state functional connectivity, assessed using fMRI Analysis still in progress
Change in White Matter Tract Integrity1 week follow upChange in integrity of the white matter tracts, assessed using diffusion tensor imaging Analysis nearly completed
Change in Grey Matter VolumeBaseline, 1 week follow upChange in grey matter volume derived from structural (T1) MRI Analysis still in progress
Change in White Matter Microstructure1 week follow upChange in white matter microstructure, specifically myelin content, assessed using MRI Multi-Parameter Mapping
Upper Limb ImpairmentBaseline, 1 week follow upUpper limb Fugl Meyer assessment score (upper limb impairment). Range 0-66, higher numbers indicate less upper limb impairment
Change in Lateralisation of Brain Activity1 week follow upChange in lateralisation of brain activity during movement of the affected hand, assessed using functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal.

Other

MeasureTime frameDescription
Baseline Structure and Function as a Correlate of Response to NeurofeedbackThroughout study completion, an average of 3 weeks.The correlation between baseline measures and change in lateralisation of brain activity during movement of the affected hand will be tested in order to identify markers to explain variability in response to real neurofeedback. Analysis still in progress

Countries

United Kingdom

Participant flow

Recruitment details

Participants were recruited from the community, between February 2018 and March 2020

Pre-assignment details

3 participants were not randomised to a group. 1 was withdrawn because the location of their stroke lesion made it impossible to deliver the intervention. 1 withdrew because they did not like the MRI scan. 1 was unable to continue due to study suspension because of the coronavirus pandemic.

Participants by arm

ArmCount
Real Neurofeedback
3 sessions of Real Neurofeedback over 1 week Neurofeedback: A visual representation of the participants brain activity during movement of their affected hand in the MRI scanner.
12
Sham Neurofeedback
3 sessions of Sham Neurofeedback over 1 week Sham Neurofeedback: A visual representation of brain activity pre-recorded from a previous participant
12
Total24

Baseline characteristics

CharacteristicTotalSham NeurofeedbackReal Neurofeedback
Affected Hand
Left
16 Participants6 Participants10 Participants
Affected Hand
Right
8 Participants6 Participants2 Participants
Age, Continuous62 years
STANDARD_DEVIATION 12
59 years
STANDARD_DEVIATION 13
64 years
STANDARD_DEVIATION 11
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United Kingdom
24 participants12 participants12 participants
Sex: Female, Male
Female
5 Participants1 Participants4 Participants
Sex: Female, Male
Male
19 Participants11 Participants8 Participants
Time since stroke76 months
STANDARD_DEVIATION 65
72 months
STANDARD_DEVIATION 63
79 months
STANDARD_DEVIATION 70

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 12
other
Total, other adverse events
0 / 120 / 12
serious
Total, serious adverse events
0 / 120 / 12

Outcome results

Primary

Hand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)

Performance on the Jebsen Taylor hand function test (time, in seconds to complete specified activities reflecting daily living)

Time frame: Throughout study completion, 5 assessment sessions spread over approximately 3 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day2238 secondsStandard Error 64
Real NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day4220 secondsStandard Error 61
Real NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day3221 secondsStandard Error 59
Real NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day5214 secondsStandard Error 61
Real NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day1267 secondsStandard Error 73
Sham NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day5249 secondsStandard Error 70
Sham NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day1274 secondsStandard Error 77
Sham NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day2270 secondsStandard Error 77
Sham NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day3267 secondsStandard Error 75
Sham NeurofeedbackHand Function Assessed With the Jebsen Taylor Hand Function Test (Time, in Seconds)Day4233 secondsStandard Error 64
p-value: >0.05Mixed Models Analysis
Primary

Lateralisation of Brain Activity

Lateralisation of brain activity during movement of the affected hand, assessed using functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal. The activation in the region of interest is calculated for each hemisphere and the laterality index calculated as: (ipsilesional hemisphere - contralesional hemisphere) / (ipsilesional hemisphere + contralesional hemisphere). As such, positive values are indicative of greater activation in the ipsilesional hemisphere.

Time frame: Throughout the 3 intervention sessions, an average of 4 days

ArmMeasureGroupValue (MEAN)
Real NeurofeedbackLateralisation of Brain ActivityDay 20.23 laterality index adjusted for baseline
Real NeurofeedbackLateralisation of Brain ActivityDay 30.26 laterality index adjusted for baseline
Real NeurofeedbackLateralisation of Brain ActivityDay 40.25 laterality index adjusted for baseline
Sham NeurofeedbackLateralisation of Brain ActivityDay 20.30 laterality index adjusted for baseline
Sham NeurofeedbackLateralisation of Brain ActivityDay 30.22 laterality index adjusted for baseline
Sham NeurofeedbackLateralisation of Brain ActivityDay 40.25 laterality index adjusted for baseline
p-value: >0.05Linear Mixed Model
Secondary

Change in Grey Matter Volume

Change in grey matter volume derived from structural (T1) MRI Analysis still in progress

Time frame: Baseline, 1 week follow up

Secondary

Change in Lateralisation of Brain Activity

Change in lateralisation of brain activity during movement of the affected hand, assessed using functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal.

Time frame: 1 week follow up

Secondary

Change in Resting State Functional Connectivity

Change in resting state functional connectivity, assessed using fMRI Analysis still in progress

Time frame: 1 week follow up

Secondary

Change in Upper Limb Function

Change in action research arm test score (ARAT; upper limb function). Range 0-57, higher numbers indicate better upper limb function

Time frame: 1 month follow up

Population: Only participants who were able to attend the 1 month follow up are included

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackChange in Upper Limb FunctionBaseline31.7 score on a scaleStandard Error 5.5
Real NeurofeedbackChange in Upper Limb Function1 month follow up34.7 score on a scaleStandard Error 5.7
Sham NeurofeedbackChange in Upper Limb FunctionBaseline38.3 score on a scaleStandard Error 3.9
Sham NeurofeedbackChange in Upper Limb Function1 month follow up38.5 score on a scaleStandard Error 3.4
Secondary

Change in White Matter Microstructure

Change in white matter microstructure, specifically myelin content, assessed using MRI Multi-Parameter Mapping

Time frame: 1 week follow up

Secondary

Change in White Matter Tract Integrity

Change in integrity of the white matter tracts, assessed using diffusion tensor imaging Analysis nearly completed

Time frame: 1 week follow up

Secondary

Lateralisation of Brain Activity During Visuomotor Squeeze Task (EEG)

Change in lateralisation of brain activity during a visuomotor squeeze task, assessed using EEG

Time frame: Throughout study completion, an average of 3 weeks

Secondary

Lateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)

Lateralisation of brain activity during a visuomotor squeeze task, assessed using functional magnetic resonance imaging (BOLD signal). The activation in the region of interest is calculated for each hemisphere and the laterality index calculated as: (ipsilesional hemisphere - contralesional hemisphere) / (ipsilesional hemisphere + contralesional hemisphere). As such, positive values are indicative of greater activation in the ipsilesional hemisphere.

Time frame: Baseline, 1 week follow up

Population: Outliers removed on the basis of head motion or laterality index greater than 2 standard deviations from the mean

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackLateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)Baseline0.31 laterality indexStandard Error 0.03
Real NeurofeedbackLateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)1 week follow up0.29 laterality indexStandard Error 0.03
Sham NeurofeedbackLateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)Baseline0.21 laterality indexStandard Error 0.06
Sham NeurofeedbackLateralisation of Brain Activity During Visuomotor Squeeze Task (MRI)1 week follow up0.28 laterality indexStandard Error 0.05
Secondary

Upper Limb Function

Action research arm test score (ARAT; upper limb function). Range 0-57, higher numbers indicate better upper limb function

Time frame: Baseline, 1 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackUpper Limb FunctionBaseline31.9 score on a scaleStandard Error 3.5
Real NeurofeedbackUpper Limb Function1 week follow up34.3 score on a scaleStandard Error 3.7
Sham NeurofeedbackUpper Limb FunctionBaseline35.3 score on a scaleStandard Error 3.9
Sham NeurofeedbackUpper Limb Function1 week follow up35.8 score on a scaleStandard Error 3.7
Secondary

Upper Limb Impairment

Upper limb Fugl Meyer assessment score (upper limb impairment). Range 0-66, higher numbers indicate less upper limb impairment

Time frame: Baseline, 1 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackUpper Limb ImpairmentBaseline44.2 score on a scaleStandard Error 2.9
Real NeurofeedbackUpper Limb Impairment1 week follow up45.8 score on a scaleStandard Error 2.2
Sham NeurofeedbackUpper Limb ImpairmentBaseline44.3 score on a scaleStandard Error 4
Sham NeurofeedbackUpper Limb Impairment1 week follow up46.3 score on a scaleStandard Error 3.5
Secondary

Upper Limb Impairment

Upper limb Fugl Meyer assessment score (upper limb impairment). Range 0-66, higher numbers indicate less upper limb impairment

Time frame: Baseline, 1 month follow up

Population: Only participants who were able to attend the 1 month follow up are included

ArmMeasureGroupValue (MEAN)Dispersion
Real NeurofeedbackUpper Limb ImpairmentBaseline45.7 score on a scaleStandard Error 3.9
Real NeurofeedbackUpper Limb Impairment1 month follow up46.6 score on a scaleStandard Error 3.9
Sham NeurofeedbackUpper Limb ImpairmentBaseline46.2 score on a scaleStandard Error 4.5
Sham NeurofeedbackUpper Limb Impairment1 month follow up47.7 score on a scaleStandard Error 3.8
Other Pre-specified

Baseline Structure and Function as a Correlate of Response to Neurofeedback

The correlation between baseline measures and change in lateralisation of brain activity during movement of the affected hand will be tested in order to identify markers to explain variability in response to real neurofeedback. Analysis still in progress

Time frame: Throughout study completion, an average of 3 weeks.

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026